Windlas Biotech standalone net profit declines 0.11% in the June 2026 quarter

Sales rise 18.09% to Rs 248.10 crore

Net profit of Windlas Biotech declined 0.11% to Rs 17.65 crore in the quarter ended June 2026 as against Rs 17.67 crore during the previous quarter ended June 2025. Sales rose 18.09% to Rs 248.10 crore in the quarter ended June 2026 as against Rs 210.09 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	248.10	210.09	18
OPM %	10.75	12.63	-
PBDT	30.14	30.71	-2
PBT	22.93	23.26	-1
NP	17.65	17.67	0

Powered by Capital Market - Live News